These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 36129297)
1. The Heptaprenyl Diphosphate Synthase (Coq1) Is the Target of a Lipophilic Bisphosphonate That Protects Mice against Toxoplasma gondii Infection. Sleda MA; Li ZH; Behera R; Baierna B; Li C; Jumpathong J; Malwal SR; Kawamukai M; Oldfield E; Moreno SNJ mBio; 2022 Oct; 13(5):e0196622. PubMed ID: 36129297 [TBL] [Abstract][Full Text] [Related]
2. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates. Ling Y; Li ZH; Miranda K; Oldfield E; Moreno SN J Biol Chem; 2007 Oct; 282(42):30804-16. PubMed ID: 17724033 [TBL] [Abstract][Full Text] [Related]
3. Lipophilic bisphosphonates reduced cyst burden and ameliorated hyperactivity of mice chronically infected with Sleda MA; Pitafi ZF; Song W; Oldfield E; Moreno SNJ mBio; 2024 Nov; 15(11):e0175624. PubMed ID: 39387586 [TBL] [Abstract][Full Text] [Related]
4. Synergistic Activity between Statins and Bisphosphonates against Acute Experimental Toxoplasmosis. Li ZH; Li C; Szajnman SH; Rodriguez JB; Moreno SNJ Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559264 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase. Szajnman SH; García Liñares GE; Li ZH; Jiang C; Galizzi M; Bontempi EJ; Ferella M; Moreno SN; Docampo R; Rodriguez JB Bioorg Med Chem; 2008 Mar; 16(6):3283-90. PubMed ID: 18096393 [TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii relies on both host and parasite isoprenoids and can be rendered sensitive to atorvastatin. Li ZH; Ramakrishnan S; Striepen B; Moreno SN PLoS Pathog; 2013; 9(10):e1003665. PubMed ID: 24146616 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase. Rosso VS; Szajnman SH; Malayil L; Galizzi M; Moreno SN; Docampo R; Rodriguez JB Bioorg Med Chem; 2011 Apr; 19(7):2211-7. PubMed ID: 21419634 [TBL] [Abstract][Full Text] [Related]
8. An updated review of chemical compounds with anti-Toxoplasma gondii activity. Rodriguez JB; Szajnman SH Eur J Med Chem; 2023 Dec; 262():115885. PubMed ID: 37871407 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents. Recher M; Barboza AP; Li ZH; Galizzi M; Ferrer-Casal M; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB Eur J Med Chem; 2013 Feb; 60():431-40. PubMed ID: 23318904 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 1-alkylaminomethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii. Galaka T; Falcone BN; Li C; Szajnman SH; Moreno SNJ; Docampo R; Rodriguez JB Bioorg Med Chem; 2019 Aug; 27(16):3663-3673. PubMed ID: 31296439 [TBL] [Abstract][Full Text] [Related]
11. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations. Ling Y; Sahota G; Odeh S; Chan JM; Araujo FG; Moreno SN; Oldfield E J Med Chem; 2005 May; 48(9):3130-40. PubMed ID: 15857119 [TBL] [Abstract][Full Text] [Related]
13. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain. Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321 [TBL] [Abstract][Full Text] [Related]
14. A solanesyl-diphosphate synthase localizes in glycosomes of Trypanosoma cruzi. Ferella M; Montalvetti A; Rohloff P; Miranda K; Fang J; Reina S; Kawamukai M; Búa J; Nilsson D; Pravia C; Katzin A; Cassera MB; Aslund L; Andersson B; Docampo R; Bontempi EJ J Biol Chem; 2006 Dec; 281(51):39339-48. PubMed ID: 17062572 [TBL] [Abstract][Full Text] [Related]
15. Anti-infectives targeting the isoprenoid pathway of Toxoplasma gondii. Moreno SN; Li ZH Expert Opin Ther Targets; 2008 Mar; 12(3):253-63. PubMed ID: 18269336 [TBL] [Abstract][Full Text] [Related]
16. Polyether ionophore kijimicin inhibits growth of Toxoplasma gondii and controls acute toxoplasmosis in mice. Leesombun A; Nihei CI; Kondoh D; Nishikawa Y Parasitol Res; 2022 Jan; 121(1):413-422. PubMed ID: 34750652 [TBL] [Abstract][Full Text] [Related]
17. Targeting isoprenoid biosynthesis for drug discovery: bench to bedside. Oldfield E Acc Chem Res; 2010 Sep; 43(9):1216-26. PubMed ID: 20560544 [TBL] [Abstract][Full Text] [Related]
18. Live Attenuated Pru:Δcdpk2 Strain of Toxoplasma gondii Protects Against Acute, Chronic, and Congenital Toxoplasmosis. Wang JL; Li TT; Elsheikha HM; Chen K; Cong W; Yang WB; Bai MJ; Huang SY; Zhu XQ J Infect Dis; 2018 Jul; 218(5):768-777. PubMed ID: 29669003 [TBL] [Abstract][Full Text] [Related]
19. Pantothenic acid biosynthesis in the parasite Toxoplasma gondii: a target for chemotherapy. Mageed SN; Cunningham F; Hung AW; Silvestre HL; Wen S; Blundell TL; Abell C; McConkey GA Antimicrob Agents Chemother; 2014 Nov; 58(11):6345-53. PubMed ID: 25049241 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo characterization of a novel insect decaprenyl diphosphate synthase: a two-major step catalytic mechanism is proposed. Zhang H; Li ZX Biochem Biophys Res Commun; 2013 Dec; 442(1-2):105-11. PubMed ID: 24246678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]